Websites targeting keyword opdivo
8 websites are using keyword opdivo in their content.
Total results: 8
Domains on this page: 8
Results:
OPDIVO® (nivolumab) | Patient Gatewayhttp://portalrankings.com/info/opdivo.com
OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.
- Updated On (Date): 2016-Nov-01
- Expiration time: 2017-Nov-06
- Website Registered On (Date): 2012-Nov-06
opdivo.jphttp://portalrankings.com/info/opdivo.jp
- Updated On (Date): 2016-Nov-16
- Expiration time: 2017-Oct-31
- Website Registered On (Date): 2013-Oct-31
Доставка препаратов по сниженым ценамhttp://portalrankings.com/info/bp-pharma.com.ua
Наш сервис позволяет Вам легко найти, выбрать и купить качественные лекарственные препараты
- Google Analytics code: 101896653-1
- Expiration time: 2019-Feb-06
- Website Registered On (Date): 2017-Feb-06
OPDIVO® (nivolumab) | Information for Healthcare Professionalshttp://portalrankings.com/info/opdivohcp.com
Learn more about OPDIVO® (nivolumab). Prescribed medication to treat certain types of cancers. Read about its indications, clinical data and efficacy.
- Updated On (Date): 2017-Feb-27
- Expiration time: 2018-Mar-03
- Website Registered On (Date): 2014-Mar-03
immunooncology.behttp://portalrankings.com/info/immunooncology.be
- Website Registered On (Date): 2011-May-13
����ܿ�pd1��ҽ��-�����ܼ�http://portalrankings.com/info/qin99.cn
香港能开pd1的医生 , 上海使用opdivo的费用, 施贵宝opdivo南京有没有卖的, 广东使用opdivo需要多少钱啊, 郑州大医院keytruda多少钱, 广州使用pd1药物价钱, 济南使用keytruda需要多少费用啊, 山东大医院做keytruda费用, 山东多长时间可以做opdivo, 香港现在个PD1抗体多钱
- Expiration time: 2017-Oct-10
- Website Registered On (Date): 2015-Oct-10
OPDIVO® (nivolumab) | Patients | Advanced Urothelial Carcinoma (Bladder Cancer)http://portalrankings.com/info/opdivoinformation.com
Information for consumers about OPDIVO® (nivolumab), a prescription medicine for previously treated bladder cancer (urothelial carcinoma) that has spread or grown. See Indication and Important Safety Information.
- Updated On (Date): 2017-Oct-06
- Expiration time: 2018-Oct-10
- Website Registered On (Date): 2016-Oct-10
OPDIVO® (nivolumab) | HCP | Metastatic Urothelial Carcinoma (mUC)http://portalrankings.com/info/opdivoinformationhcp.com
OPDIVO® (nivolumab), for treatment of patients with previously treated locally advanced or metastatic urothelial carcinoma. See Indication and Important Safety Information.
- Updated On (Date): 2017-Oct-06
- Expiration time: 2018-Oct-10
- Website Registered On (Date): 2016-Oct-10